key: cord-0704631-fnkiwuta authors: Eleiwa, Taher K.; Gaier, Eric D.; Haseeb, Abid; ElSheikh, Reem H.; Sallam, Ahmed B.; Elhusseiny, Abdelrahman M. title: Adverse Ocular Events following COVID-19 Vaccination date: 2021-09-24 journal: Inflamm Res DOI: 10.1007/s00011-021-01506-6 sha: aba4ac4445272aa3d308429178500ec65a87fd64 doc_id: 704631 cord_uid: fnkiwuta nan We read with interest the article "Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose" by Santovito and Pinna [1] . The timeline of events beginning after the vaccination supports that the exposure caused the patient's symptoms. However, little insight can be gained without a corroborative neuroophthalmic examination within the window that the patient exhibited symptoms. The neurologic and ophthalmic manifestations of SARS-CoV-2 (COVID- 19) are well established. In one study, COVID-19 infection resulted in ocular manifestations in 1.4% of patients; a review of the literature indicates that these manifestations most frequently result in reactive inflammation of the eyelids, follicular conjunctivitis, eye redness, foreign body sensation, and eye discharge [2] [3] [4] [5] [6] [7] . Regarding neuro-ophthalmologic manifestations, optic neuritis has been reported in several reports at various stages of COVID-19 infection [8] [9] [10] [11] [12] [13] . Several case reports have reported on cranial nerve palsies, particularly oculomotor (third cranial) nerve and abducens (sixth cranial) nerve palsies presenting with diplopia and/or ophthalmoplegia [14] [15] [16] [17] [18] [19] [20] . However, these ophthalmologic and neuro-ophthalmologic manifestations are non-specific, so definitive attribution to a particular exposure is generally difficult. In the current case, the onset, course, and duration of the reported symptoms narrow the field of etiological possibilities to the inflammatory and vascular categories. Optic neuritis may manifest with reduction of visual acuity and darkening of the visual field, accompanied by pain exacerbated with ocular movement. In a review of adverse ocular events from 2010 to 2020, optic neuritis was found to be the most common event associated with nine different vaccines with a mean onset of 10.8 days (range: 1 day-1 month) post-injection [21] . The mechanism underlying optic neuritis in the setting of vaccination is not well understood; previous studies have suggested molecular mimicry between myelin basic protein and viral proteins, epitope spreading, bystander activation, and superantigen activation as potential mechanisms [22] [23] [24] [25] [26] . Visual prognosis is generally favorable, but ideal management remains elusive [21, 27] . Regarding the case presented by Santovito and Pinna, the likelihood the patient had an optic neuropathy is low given the brief duration (hours) of symptoms. Transient visual obscurations associated with optic disc edema (even that secondary to increased intracranial pressure, i.e., papilledema) are another consideration, but these events tend to manifest on the order of seconds and are elicited by transient increases in intrathoracic/central venous pressure. We cannot know if the patient had optic neuritis or optic disc edema that was present for longer than his symptoms without an examination. Presumed inflammatory cranial neuropathies in general are common among patients after vaccines. We recently encountered a 46-year-old male patient who developed torsional, binocular diplopia 3 days after the second dose of Oxford-AstraZeneca ChAdOx1 nCoV-19 (AZD1222). Examination revealed a pattern of strabismus fitting that of a right 4th cranial nerve palsy. Paretic ophthalmoplegia has also been reported with active COVID-19 infection. Falcone et al. reported a case of abducens cranial nerve palsy underlying binocular, horizonal diplopia in an otherwise healthy 32-year-old man 3 days after developing upper respiratory symptoms later confirmed to be COVID-19 infection [16] . Magnetic resonance imaging confirmed lateral rectus atrophy in the patient. Faucher et al. reported a case of oculomotor nerve palsy in an otherwise healthy 21-year-old man 2 weeks after COVID-19 infection manifesting after hospital discharge [28] . Intraocular inflammation is another possible mechanism by which the reported patient may have experienced his visual symptoms. Since February 2021, 46 reports of ocular side effects linked to the COVID-19 vaccine have been reported to the Vaccine Adverse Event Reporting System (VAERS) [21, 29] . The majority (74%) involve the eyelid or conjunctiva [29, 30] . Inflammation of the optic nerve, retina, uveal tract, and anterior segment, combined to account for 9% of VAERS [30] . We recently reported a case of acute juvenile idiopathic arthritis-associated uveitis 5 days after the 2nd dose of Sinopharm COVID-19 vaccine in an 18-year-old girl [31] . Panuveitis [32] and central serous retinopathy [33] have also been reported. Despite the above-mentioned associations, the rapid resolution of visual symptoms over the course of hours argues against a uveitic process. It would be highly unusual for ocular inflammation to manifest and then self-resolve within hours. Photophobia, a hallmark symptomatic feature of uveitis, was not reported by the patient. Table 1 summarizes our review of literature from 16 publications reporting on 20 patients with ocular complications following COVID-19 vaccinations. In brief, these included graft rejections , macular neuroretinopathy [39] [40] [41] , multifocal choroiditis [42, 43] , acute uveitis [, 32, 44, 45] , central serous retinopathy [33] , arteritic anterior ischemic optic neuropathy [46] , and acute zonal occult outer retinopathy [46] . In our opinion, the most likely explanation is that the patient suffered visual symptoms related to the central, systemic illness triggered by the vaccine. The presence of systemic symptoms (headache, dizziness and fatigue, and nausea) that accompanied and resolved with his visual symptoms reflect and support this hypothesis. Hypoperfusion Ultimately, reporting of this patient's vaccine triggered very transient visual symptoms as described is of little value without a corroborating examination or objective evidence of ophthalmic pathology. The relevance of optic neuritis, inflammatory cranial neuropathies, and ocular inflammation and uveitis to this case is suspect for the same reason. No doubt there is a miriad of ways in which vaccines, particularly second doses or first doses in previous infected individuals, can affect the eyes and visual pathways to produce visual symptoms. Reporting of these symptoms as in the case of Santovito and Pinna is very commanded. However, reports of these adverse events should always be verified and supported by objective data from clinical examination and ancillary testing if a causal relationship is to be asserted. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan COVID-19 and the ocular surface: a review of transmission and manifestations Ocular manifestations of COVID-19 (SARS-CoV-2): a critical review of current literature The ocular manifestations and transmission of COVID-19: recommendations for prevention Orbital inflammatory disease associated with COVID-19 infection Phlyctenular keratoconjunctivitis in a patient with COVID-19 infection Optic neuritis post-COVID-19 infection. A case report with meta-analysis. Interdiscip Neurosurg Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19) Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: a case report Optic neuritis in a child with COVID-19: a rare association COVID-19-induced acute bilateral optic neuritis Optic neuritis as a presenting symptom of post-COVID-19 multisystem inflammatory syndrome in children (MIS-C) Isolated third cranial nerve palsy and COVID-19 infection in a child Abducens palsy and anosmia associated with COVID-19: a case report Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19) Unilateral diplopia and ptosis in a child with COVID-19 revealing third cranial nerve palsy Third cranial nerve palsy due to COVID-19 infection COVID-19 presenting with ophthalmoparesis from cranial nerve palsy Oculomotor nerve palsy in an asymptomatic child with COVID-19 Ocular adverse events following vaccination: overview and update High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response Viruses, hidden self-epitopes and autoimmunity Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading Optic neuritis after influenza vaccination A literature review on optic neuritis following vaccination against virus infections Isolated post SARS-CoV-2 diplopia US Centers for Disease Control and Prevention. CDC WONDER online database Ocular adverse events following vaccination: overview and update. Survey oOphthalmol Acute uveitis following COVID-19 vaccination Panuveitis following vaccination for COVID-19 Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine Keratoplasty rejection after the BNT162b2 messenger RNA vaccine Corneal graft rejection after COVID-19 vaccination Corneal graft rejection following COVID-19 vaccine. Eye (Lond) Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine Acute corneal endothelial graft rejection following COVID-19 vaccination Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2 Acute macular neuroretinopathy following coronavirus disease 2019 vaccination Acute macular neuroretinopathy following COVID-19 vaccination. Eye (Lond) COVID-19 vaccination and bilateral multifocal choroiditis Bilateral multifocal choroiditis following COVID-19 vaccination Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? COVID-19 recombinant mrna vaccines and serious ocular inflammatory side effects: real or coincidence?